These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24278528)

  • 1. General Pharmacology of Artesunate, a Commonly used Antimalarial Drug:Effects on Central Nervous, Cardiovascular, and Respiratory System.
    Lee HA; Kim KS; Kim EJ
    Toxicol Res; 2010 Sep; 26(3):223-32. PubMed ID: 24278528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General pharmacology of DW-286a, a new fluoronaphthyridone antibiotic: effects on central nervous, cardiovascular, and respiratory systems.
    Kim EJ; Shin WH
    Biol Pharm Bull; 2004 May; 27(5):641-6. PubMed ID: 15133237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety pharmacology of sibutramine mesylate, an anti-obesity drug.
    Kim EJ; Park EK; Suh KH
    Hum Exp Toxicol; 2005 Mar; 24(3):109-19. PubMed ID: 15901050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General pharmacology of IY-81149, a new proton pump inhibitor.
    Kim EJ; Lee RK; Lee SM; Kim DY
    Arzneimittelforschung; 2001 Jan; 51(1):51-9. PubMed ID: 11215326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [General pharmacology of T-3761, a new oral quinolone antibacterial agent (2). Effect on the respiratory and cardiovascular systems, autonomic nervous system and other functions].
    Furuhata K; Hiraiwa T; Terashima N; Arai H; Ono S; Hashiba K; Maekawa M; Kitamura K; Nakada Y; Mori Y
    Jpn J Antibiot; 1995 May; 48(5):706-32. PubMed ID: 7637205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
    Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
    Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General pharmacology of CKD-732, a new anticancer agent: effects on central nervous, cardiovascular, and respiratory system.
    Kim EJ; Shin WH
    Biol Pharm Bull; 2005 Feb; 28(2):217-23. PubMed ID: 15684472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacological properties of Sho-seiryu-to (TJ-19) extracts.
    Amagaya S; Iizuka A; Makino B; Kubo M; Komatsu Y; Cheng FC; Ruo TI; Itoh T; Terasawa K
    Phytomedicine; 2001 Sep; 8(5):338-47. PubMed ID: 11695876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
    Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
    Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacological properties of muroctasin.
    Kojima H; Hirohashi M; Kasai Y; Takasuna K; Fukumoto C; Akashi A
    Arzneimittelforschung; 1988 Jul; 38(7A):1002-9. PubMed ID: 3190791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacological properties of TJ-9 extract.
    Amagaya S; Ishige A; Takeda S; Shindo S; Maemura S; Kubo M; Komatsu Y; Okada M; Itoh T; Terasawa K
    Phytomedicine; 1998 May; 5(3):165-75. PubMed ID: 23195837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacology of the new antiviral agent SK 1899.
    Ryu KH; Rhee HI; Jung I; Kim TS; Lee SJ; Im GJ; Lee N; Ryu DH; Kim YW; Kim JJ; Chang K; Lee BH; Shin HS; Kim EJ; Kim KH; Kim DK
    Arzneimittelforschung; 2000 Apr; 50(4):395-403. PubMed ID: 10800640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [General pharmacology of aclacinomycin A (author's transl)].
    Ohmori K; Hirano S; Hori S
    Jpn J Antibiot; 1980 Feb; 33(2):192-213. PubMed ID: 6929361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.